14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.07 $1.07 Wednesday, 6th Dec 2023 SURF stock ended at $1.07. During the day the stock fluctuated 0% from a day low at $1.07 to a day high of $1.07.
90 days $1.01 $1.09
52 weeks $0.555 $1.12

Historical Surface Oncology Inc. prices

Date Open High Low Close Volume
Oct 31, 2023 $1.07 $1.07 $1.07 $1.07 0
Oct 30, 2023 $1.07 $1.07 $1.07 $1.07 0
Oct 27, 2023 $1.07 $1.07 $1.07 $1.07 0
Oct 26, 2023 $1.07 $1.07 $1.07 $1.07 0
Oct 25, 2023 $1.07 $1.07 $1.07 $1.07 0
Oct 24, 2023 $1.07 $1.07 $1.07 $1.07 0
Oct 23, 2023 $1.07 $1.07 $1.07 $1.07 0
Oct 20, 2023 $1.07 $1.07 $1.07 $1.07 0
Oct 19, 2023 $1.07 $1.07 $1.07 $1.07 0
Oct 18, 2023 $1.07 $1.07 $1.07 $1.07 0
Oct 17, 2023 $1.07 $1.07 $1.07 $1.07 0
Oct 16, 2023 $1.07 $1.07 $1.07 $1.07 0
Oct 13, 2023 $1.07 $1.07 $1.07 $1.07 0
Oct 12, 2023 $1.07 $1.07 $1.07 $1.07 0
Oct 11, 2023 $1.07 $1.07 $1.07 $1.07 0
Oct 10, 2023 $1.07 $1.07 $1.07 $1.07 0
Oct 09, 2023 $1.07 $1.07 $1.07 $1.07 0
Oct 06, 2023 $1.07 $1.07 $1.07 $1.07 0
Oct 05, 2023 $1.07 $1.07 $1.07 $1.07 0
Oct 04, 2023 $1.07 $1.07 $1.07 $1.07 0
Oct 03, 2023 $1.07 $1.07 $1.07 $1.07 0
Oct 02, 2023 $1.07 $1.07 $1.07 $1.07 0
Sep 29, 2023 $1.07 $1.07 $1.07 $1.07 0
Sep 28, 2023 $1.07 $1.07 $1.07 $1.07 0
Sep 27, 2023 $1.07 $1.07 $1.07 $1.07 0
Click to get the best stock tips daily for free!

About Surface Oncology Inc.

Surface Oncology. Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibody that inhibits CD39 enzymatic activity for the production of adenosine and the breakdown of adenosine... SURF Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT